In areas of high impact, 72% of patients with scalp psoriasis and 85% with genital psoriasis treated with icotrokinra achieved site-specific clear or almost clear skin at Week 52 in… Read More
KIRKLAND, QC – Pfizer Canada is pleased to announce that ABRYSVO, its vaccine for the prevention of Respiratory Syncytial Virus (RSV), has been selected for public funding in multiple provinces… Read More
Preliminary efficacy data, combined with a tolerable safety profile, reinforce the potential of ZW191 in patients with advanced solid tumors, including ovarian, endometrial, and non-small cell lung cancer 64% overall… Read More
Data presented on outcomes following treatment with CFTR modulators add to growing body of evidence that reduced level of sweat chloride is associated with improved clinical outcomes, particularly in younger… Read More
Investment to support clinical studies of Sonus Microsystem’s wearable ultrasound patch VANCOUVER, BC – Providence Health Care Ventures (PHCV), a strategic catalyst for health care innovation, announced a strategic investment in… Read More
